bibliographic entry 9455883 [be/9455883]
https://w3id.org/oc/corpus/be/9455883

is a
content
  • Benson DM, Hofmeister CC, Padmanabhan S, Suvannasankha A, Jagannath S, et al (2012) A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma. Blood 120: 4324–4333. doi: 10.1182/blood-2012-06-438028 PMID: 23033266
references